HOME >> BIOLOGY >> NEWS
Study finds fecal microbes high in New Orleans sediments following Hurricanes Katrina and Rita

MBL, WOODS HOLE, MAIn a new study documenting the microbial landscape of New Orleans and Lake Pontchartrain in the wake of Hurricanes Katrina and Rita, scientists report that sediments in interior portions of the city appear to be contaminated with fecal microbes, a chronic condition they say persisted in the area before the hurricanes, and that the resulting water quality in the city and in nearshore waters of the lake continues to be impacted by discharges from this contamination.

According to the study authors, including Marine Biological Laboratory (MBL) Assistant Research Scientist, Dr. Linda Amaral Zettler, while floodwaters pumped from New Orleans back into Lake Ponchartrain following the Hurricanes showed higher-than-normal levels of bacteria and pathogens, fecal indicator microbe and pathogen concentrations in the lake returned to pre-hurricane levels within two months. However, the sediments left behind in the flooded regions of the city appear to contain microbes commonly found in sewage treatment and remain a cause for concern because they may serve as a potential source of ongoing microbial exposure.

The report, which appears this week's Online Early Edition of The Proceedings of the National Academy of Sciences, maintains that further investigation is needed to evaluate the microbial quality of floodwater sediments deposited in the New Orleans area and highly recommends epidemiologic studies to determine whether there is an elevated risk of exposure to human pathogens through contact, ingestion, and inhalation of these sediments.

The study was a collaborative response of several institutions, including the Woods Hole Center for Oceans and Human Health, of which the MBL and Amaral Zettler are a part. The researchers began collecting water and sediment samples from the interior canals and shoreline of New Orleans and the offshore waters of Lake Pontchartrain in October 2005 after the floodwaters had receded. They examin
'"/>

Contact: Gina Hebert
ghebert@mbl.edu
508-289-7725
Marine Biological Laboratory
3-May-2007


Page: 1 2 3

Related biology news :

1. Study begins to reveal clues to the cause and progression of sepsis
2. Study finds gender differences in renal and other genes contributing to blood pressure
3. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
4. Study: Sticking to the sand might not be such good, clean fun for beachgoers
5. Study points to new way to predict death risk from torn aorta
6. Study identifies new gene therapy tools for inherited blindness
7. Study finds contaminated water reaching Floridas offshore keys
8. Study sheds light on why humans walk on two legs
9. Study explains how pathogens evolve to escape detection
10. Study finds hereditary link to premenstrual depression
11. Study identifies energy efficiency as reason for evolution of upright walking

Post Your Comments:
(Date:2/5/2015)... 2015 Despite a lack of advancements ... as consumer electronics, automotive, storage and telecommunication has ... (SMT) screen printers. Innovations in electronics and conversion ... the adoption curve up. Meanwhile, sale volumes of ... dispensers are indispensable in the production of complex ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a ... discovery, announced the launch of a TR-FRET (time ... company,s Transcreener UDP Assay, a high throughput screening ... new assay will allow for sensitive detection of ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
(Date:3/3/2015)... , March 3, 2015 Fried, Frank, Harris, ... I.D. Lewis has joined the Firm as a ... the New York office. Mr. ... matters, as well as other intellectual property and general ... Mr. Lewis represents both plaintiffs and defendants in a ...
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... AtheroNova Inc. (OTCQB: AHRO) today announced that the ... under Chapter 11 of the U.S. Bankruptcy Code in the ... , Santa Ana division (the "Bankruptcy ... are expected to be jointly administered. The Company ... sale process, for all or substantially all of its assets ...
(Date:3/3/2015)... Switzerland (PRWEB) March 03, 2015 ... for drug discovery and life science research, today ... Biologics (TM) enterprise platform for use at Pfizer ... and Europe. Genedata is supporting Pfizer’s global deployment ... Technologies (GBT), Centers for Therapeutic Innovation (CTI), and ...
Breaking Biology Technology:Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3
Cached News: